Skip to main content
. 2014 Jun 9;32(21):2206–2216. doi: 10.1200/JCO.2013.52.8257

Table 3.

Patient and Diagnosing Surgeon Factors Associated With Omission of Needle Biopsy Among Patients With Surgeon Consultation Before Biopsy (n = 10,981 diagnosing surgeons; n = 60,018 patients)

Predictor No. of Patients No. of Patients With Needle Biopsy Unadjusted
Adjusted
RR 95% CI P* RR 95% CI P*
Patient factors
    Age, years
        < 70 11,836 6,436 1
        70-79 34,629 18,748 1.01 0.98 to 1.03 .678 NS
        ≥ 80 13,553 6,994 1.07 1.04 to 1.11 < .001 NS
    Race/ethnicity
        White 55,317 29,869 1
        Black 3,396 1,679 1.10 1.05 to 1.15 < .001 NS
        Other 1,305 630 1.12 1.05 to 1.20 .002 NS
    Medicaid coverage
        Yes 3,935 1,825 1.14 1.09 to 1.18 < .001 1.06 1.02 to 1.11 .002
        No 56,083 30,353 1 1
    Year of BCS
        2003 14,374 6,706 1.38 1.35 to 1.42 < .001 1.34 1.30 to 1.37 < .001
        2004 13,021 6,527 1.28 1.24 to 1.31 < .001 1.24 1.21 to 1.28 < .001
        2005 12,075 6,591 1.16 1.12 to 1.20 < .001 1.15 1.11 to 1.18 < .001
        2006 11,814 6,998 1.02 0.99 to 1.06 .207 1.02 0.99 to 1.06 .187
        2007 8,734 5,356 1 1
    Charlson comorbidity score
        ≤ 1 54,491 29,366 1 1
        2 3,789 1,958 1.06 1.01 to 1.10 .013 1.04 1.00 to 1.09 .039
        ≥ 3 1,738 854 1.09 1.03 to 1.16 .005 1.08 1.02 to 1.14 .014
    Receipt of chemotherapy
        Yes 8,622 4,879 1 1 < .001
        No 51,396 27,299 1.14 1.11 to 1.18 < .001 1.15 1.12 to 1.18
    County of residence
        Rural 13,264 6,376 1.12 1.09 to 1.16 < .001 1.07 1.03 to 1.10 < .001
        Urban 46,754 25,802 1 1
    Distance to nearest radiologic facility performing needle biopsy, miles
        ≤ 0.6 14,739 8,112 1 1
        0.7-3.4 14,059 7,729 1.00 0.97 to 1.03 .902 1.00 0.97 to 1.03 .980
        3.5-8.1 15,021 8,396 1.00 0.97 to 1.03 .845 1.00 0.97 to 1.03 .861
        ≥ 8.2 16,199 7,941 1.09 1.06 to 1.12 < .001 1.04 1.01 to 1.07 .017
    Mammography before surgical consultation or needle biopsy
        Yes 51,529 28,109 1 1
        No 8,489 4,069 1.26 1.23 to 1.28 < .001 1.26 1.23 to 1.29 < .001
Diagnosing surgeon factors
    Board certified
        Yes 56,709 30,960 1 1
        No 3,309 1,218 1.51 1.45 to 1.57 < .001 1.32 1.25 to 1.38 < .001
    US trained
        Yes 52,480 28,852 1 1
        No 7,538 3,326 1.38 1.32 to 1.43 < .001 1.17 1.11 to 1.22 < .001
    Degree
        MD 58,385 31,522 1
        DO 1,633 656 1.40 1.30 to 1.50 < .001 NS
    Decade of medical school graduation
        Before 1980 25,905 13,064 1.53 1.26 to 1.75 < .001 1.49 1.25 to 1.69 < .001
        1980-1989 22,544 12,568 1.31 1.05 to 1.54 .018 1.36 1.14 to 1.55 .001
        1990-1999 11,413 6,446 1.25 0.98 to 1.49 .069 1.27 1.05 to 1.48 .018
        2000+ 156 100 1 1
    Case volume, No. of patients
        ≤ 5 13,496 5,407 1.81 1.77 to 1.85 < .001 1.66 1.62 to 1.70 < .001
        > 5 and ≤ 10 12,069 5,968 1.49 1.43 to 1.54 < .001 1.41 1.37 to 1.46 < .001
        > 10 and ≤ 20 14,554 8,009 1.31 1.26 to 1.36 < .001 1.27 1.22 to 1.32 < .001
        > 20 19,899 12,794 1 1
    Specialty
        Surgical oncologist 7,944 5,055 1 1
        General surgeon 50,714 26,187 1.42 1.34 to 1.51 < .001 1.11 1.04 to 1.19 .001
        Other 1,360 936 1.04 0.91 to 1.18 .534 0.77 0.66 to 0.88 < .001
    Sex
        Male 46,545 23,938 1.40 1.34 to 1.46 < .001 NS
        Female 13,473 8,240 1

Abbreviations: BCS, breast-conserving surgery; DO, doctor of osteopathy; MD, doctor of medicine; NS, not significant; RR, relative risk.

*

Statistical significance evaluated at the P = .05 level in both unadjusted and adjusted analyses. A RR > 1 indicates that the factor was associated with a lower likelihood of needle biopsy. In this model, 298 surgeons and 1,294 patients were excluded because of unknown covariates. The ratio of the generalized χ2 statistic to its df was 0.85, indicating no residual overdispersion in the model.

Surgeon case volume was defined for each surgeon as the number of patients in the cohort who underwent BCS performed by that surgeon during the time interval of the study.